LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.78 | 27.76 | 477 | 6893 | 0.0692 | 0.4297 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.78 | 27.76 | 8480 | 6893 | 1.2302 | 1.0528 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.78 | 27.76 | 949 | 6893 | 0.1377 | 0.5588 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.78 | 27.76 | 9946 | 6893 | 1.4429 | 1.0943 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.48 | 27.76 | 517 | 6957 | 0.0743 | 0.4433 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.48 | 27.76 | 8712 | 6957 | 1.2521 | 1.0572 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.48 | 27.76 | 1026 | 6957 | 0.1475 | 0.5730 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.48 | 27.76 | 10144 | 6957 | 1.4579 | 1.0969 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 75.19 | 27.76 | 554 | 7015 | 0.0790 | 0.4551 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 75.19 | 27.76 | 8925 | 7015 | 1.2722 | 1.0613 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 75.19 | 27.76 | 1048 | 7015 | 0.1494 | 0.5761 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 75.19 | 27.76 | 10384 | 7015 | 1.4802 | 1.1007 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.89 | 27.76 | 553 | 7025 | 0.0787 | 0.4546 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.89 | 27.76 | 8942 | 7025 | 1.2728 | 1.0614 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.89 | 27.76 | 1023 | 7025 | 0.1456 | 0.5711 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.89 | 27.76 | 10538 | 7025 | 1.5000 | 1.1042 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.60 | 27.76 | 457 | 7045 | 0.0649 | 0.4200 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.60 | 27.76 | 9093 | 7045 | 1.2906 | 1.0649 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.60 | 27.76 | 996 | 7045 | 0.1414 | 0.5655 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.60 | 27.76 | 10717 | 7045 | 1.5211 | 1.1078 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.31 | 27.76 | 441 | 6976 | 0.0632 | 0.4146 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.31 | 27.76 | 9341 | 6976 | 1.3390 | 1.0746 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.31 | 27.76 | 1051 | 6976 | 0.1507 | 0.5774 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.31 | 27.76 | 10901 | 6976 | 1.5626 | 1.1152 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.01 | 27.76 | 407 | 7000 | 0.0581 | 0.4001 | MN20160318_Q01 | E21 |